| Ticker: | PYXS |
| Current Price: | $1.79 |
| % Daily Change: | -3.24% |
| Volume (1,000s): | 1,558.79 |
| Average Volume (1,000s): | 930.50 |
| Market Cap (M): | $113.41 |
| 1/2/2024 Price: | $1.18 |
| Change Since Inception: | 51.69% |
Pyxis Oncology, Inc.
321 Harrison Avenue
11th Floor, Suite 1
Boston, MA 02118
United States
Pyxis Oncology is transforming the lives of patients with cancer by advancing our differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies have the potential to address difficult-to-treat cancers and improve patient outcomes.